We are live on ! Find out more
SAGE

Sage Therapeutics
SAGE

Delisted

SAGE was delisted on the 30th of July, 2025.

Back to rankings

248 hedge funds and large institutions have $4.65B invested in Sage Therapeutics in 2020 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 74 increasing their positions, 85 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% more first-time investments, than exits

New positions opened: 51 | Existing positions closed: 33

43% more capital invested

Capital invested by funds: $3.26B → $4.65B (+$1.39B)

18% more call options, than puts

Call options by funds: $54.8M | Put options by funds: $46.6M

8% more funds holding

Funds holding: 230 → 248 (+18)

0.12% more ownership

Funds ownership: 103.25% → 103.37% (+0.12%)

0% more funds holding in top 10

Funds holding in top 10: 7 → 7 (0)

13% less repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 85

Holders
248
Holders Change
+18
Holders Change %
+7.83%
% of All Funds
4.39%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.12%
New
51
Increased
74
Reduced
85
Closed
33
Calls
$54.8M
Puts
$46.6M
Net Calls
+$8.17M
Net Calls Change
-$24.4M

Top Buyers

1
Wellington Management Group
Wellington Management Group
Massachusetts
+$298M
2
Deutsche Bank
Deutsche Bank
Germany
+$32.5M
3
PA
Perceptive Advisors
New York
+$32.4M
4
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$26.5M
5
MWNA
Marshall Wace North America
New York
+$22.1M

Top Sellers

1
GPP
Great Point Partners
Connecticut
-$111M
2
Citadel Advisors
Citadel Advisors
Florida
-$68.2M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$36.9M
4
BCLSI
Bain Capital Life Sciences Investors
Massachusetts
-$30.5M
5
Victory Capital Management
Victory Capital Management
Texas
-$25.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
Point72 Asset Management
251
Point72 Asset Management
Connecticut
– -$18.5M -302,214 Closed
LGM
252
Logos Global Management
California
– -$15.3M -250,000 Closed
MCM
253
Moore Capital Management
New York
– -$10.3M -168,975 Closed
Balyasny Asset Management
254
Balyasny Asset Management
Illinois
– -$8.7M -142,289 Closed
NIP
255
Nicholas Investment Partners
California
– -$6.46M -105,771 Closed
CSS
256
Cubist Systematic Strategies
Connecticut
– -$2.53M -41,459 Closed
CGL
257
Clarius Group LLC
Washington
– -$2.17M -35,500 Closed
PP
258
Paloma Partners
Connecticut
– -$1.86M -30,467 Closed
GH
259
GAM Holding
Switzerland
– -$1.83M -30,000 Closed
ECM
260
Endurant Capital Management
California
– -$1.44M -23,588 Closed
DA
261
Duality Advisers
Florida
– -$1.32M -21,590 Closed
Group One Trading
262
Group One Trading
Illinois
– -$803K -10,898 Closed
OMC
263
Old Mission Capital
Illinois
– -$554K -9,063 Closed
AC
264
Amia Capital
United Kingdom
– -$467K -7,644 Closed
WCM
265
Weld Capital Management
New York
– -$391K -6,392 Closed
Parallax Volatility Advisers
266
Parallax Volatility Advisers
California
– -$370K -6,051 Closed
TCM
267
Teza Capital Management
Illinois
– -$321K -5,254 Closed
TC
268
Tarsadia Capital
New York
– -$306K -5,000 Closed
QT
269
Quantamental Technologies
New York
– -$287K -4,700 Closed
B
270
Bailard
California
– -$275K -4,500 Closed
Holocene Advisors
271
Holocene Advisors
New York
– -$200K -3,277 Closed
BAM
272
Belpointe Asset Management
Nevada
– -$108K -1,760 Closed
Lazard Asset Management
273
Lazard Asset Management
New York
– -$101K -1,658 Closed
PFS
274
Prospera Financial Services
Texas
– -$68K -1,118 Closed
GT
275
Glenmede Trust
Pennsylvania
– -$20K -335 Closed
8 9 10
11
12

SAGE Hedge Fund Activity: Q4 2020 in Review

248 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Sage Therapeutics (SAGE) for Q4 2020, worth a combined $4.65B — up 43% from $3.26B a quarter earlier.

Buyers outnumbered sellers: 51 funds opened new SAGE positions and 33 closed out — a net gain of 18 holders — while 74 added to existing stakes and 85 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $298M. The largest seller was Great Point Partners, cutting an estimated $111M.

  • 248 institutional investors held Sage Therapeutics (SAGE) as of Q4 2020, up from 230 in Q3 2020.
  • Funds reported $4.65B of Sage Therapeutics stock for Q4 2020, up 43% quarter-over-quarter.
  • 51 funds opened new Sage Therapeutics positions in Q4 2020 and 33 closed out, a net change of +18 holders.
  • The largest Sage Therapeutics buyer in Q4 2020 was Wellington Management Group, an estimated $298M added.
  • The largest Sage Therapeutics seller in Q4 2020 was Great Point Partners, an estimated $111M sold.

Based on aggregated 13F filings for Q4 2020.